16/17 - TB AntiMycobacterials Flashcards

(33 cards)

1
Q

2nd Line TB Agents
for
Drug-Resistant TB
or
Problems of Tolerance to 1st line agents

A
  • *FLUOROQUINOLONES**
  • *Levo-Moxi-Gati**
  • *OXAZOLIDINONES**
  • *Linezolid**
  • *Diarylquinoline**
  • *BEDAQUILINE**
  • Nitroaromatics = Nitroimidazoles*
  • *Pretomanid & Delamanid**
  • still in trials for LATENT TB*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HIV & TB
Co-Infection

Symptoms & Treatment

A
  • *IRIS**
  • *Immune Reconsititution Inflammatory Syndrome**
  • *Mild –> IBUPROFEN**
  • *SEVERE –> CORTICOSTEROID**

high fevers

  • worsening respiratory symptoms
  • Inflamed lymph nodes
  • new lymphadenopathy
  • expanding CNS lesions,
  • worsening of pulmonary parenchymal infiltrations
  • new/increasing pleural effusions,
  • intra-abdominal or retroperitoneal abscesses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Treatment of
M.Avium Complex

Non-Tuberculous Mycobacteria = NTM

A

REM-A

Rifamycin

Ethambutol

Macrolide

AMINOGLYCOSIDE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  • *Nitroaromatics = Nitroimidazoles**
  • *Pretomanid & Delamanid**

Uses for TB / Toxicities

A

Bacterial PRODRUG
require activation by M. TB

Active vs BOTH:
NON-REPLICATING TB
=LATENT TB

likely due to :
multiple molecular targets due to liberation of NA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  • *Rifapentine Uses**
  • in comparison to RIFAMPIN*
A
  • *LONGER HALF LIFE**
  • *intermittent dosing** –> 2x a week for initial phase

ONCE A WEEK in Continuation phase

not active against Rifampin-resistant strains of M. TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pyrazinamide Resistance

significant HEPATOTOXICITY
↑ALT / ↑AST

A

Resistance via:
pncA mutations
pyrazinamidase used to activate –> pyrazinoic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Is this drug a Bacterial Activated PRODRUG?
What activates it?

PYRAZINAMIDE

A

YES

pncA
pyrazinamidase
VVV
pyrazinoic acid = active agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which TB Drug based on Target?

inhibits:
ARABINOSYL TRANSFERASE
affecting the synthesis of:
arabinogalactan & lipoarabinomannan in cell wall

A

ETHAMBUTOL

OPTIC NEURITIS
visual acuity –> red-green differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

TB TREATMENT
for
Intensive Phase

A

2 MONTHS DAILY
Kills 99% of bacteria

ISONIAZID = INH

RIFAMPIN

PYRAZINAMIDE

Ethambutol
not used if other 3 are sufficient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

​Treatment & Duration for:

HIV & TB Co-infection

A

If Recieving ART –> standard Regimen
CD4 < 50 = start within weeks
CDC > 50 = start within 8-12 weeks

  • If NOT recieving ART*
  • *extend continuation phase for +3 months (7 months)**

RIFABUTIN
may be substituted for rifampin –> reduce CYP450 induction
may need dosage adjustment with some PI’s & NNRTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Oxazolidinones

Uses for TB / Concerns

A

LINEZOLID
targets the ribosome

Active against MDR & XDR-TB = Resistant TB
but…
BONE MARROW TOXICITY
need for long treatment

myelosuppression / various neuropathies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fluoroquinolones

Uses for TB / Concerns

A

Moxifloxacin
Gatifloxacin + Levofloxicin

Used for:
DRUG-RESISTANT TB

Inhibit - DNA Gyrase

Resistance:
Mutations in gyrA subunit

AORTIC RUPTURES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  • *Is this drug a Bacterial Activated PRODRUG?**
  • *What activates it?**

ISONIAZID

A

YES

  • *katG**
  • *catalase peroxidase**

also:
Ethionamide = monooxygenase etA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

DiarylQuinoline = Bedaquiline

Uses for TB

A

Targets: ATP-SYNTHASE
5 month half life –> single dose

highly potent vs:
NON-REPLICATING M.TB = LATENT TB

FDA approved for MDR-TB when no other options available

Adr:
Prolonged QT Interval + Hepatotoxicities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ethambutol Resistance

OPTIC NEURITIS

A

very low resistance

OVERexpression of:
embA**+**embB**+**embC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

​Treatment & Duration for:

Single-drug resistant ACTIVE TB

A

replace resistant drug with:
FLUOROQUINOLONE

Moxi-Levo-Gati

If RIFAMPIN-Resistant –> extend to 12 months

17
Q

Isoniazid Resistance

PERIPHERAL NEURITIS –> GIVE B6

HEPATOTOXICITY

A

65% in

  • *katG** = activating enzyme
  • *Missense** or Large deletions in catalase peroxidase

20% in

  • *inhA** = final target
  • *mutations in NADH binding site**
18
Q

Diagnosis of TB

A

Definitive Diagnosis:
CULTURE

S/Sx:
Weight Loss / Night Sweats / Cough
HEMOPTYSIS
-blood in sputum

CXR

AFB = Acid Fast Bacilli in Sputum

19
Q
  • *Non-Tuberculous Mycobacteria = NTM**
  • *Pulmonary Infection**

TREATMENT

A

“REM” for 12 months of culture-negative sputum

RIFAMPIN

ETHAMBUTOL

MACROLIDE
clarithroycin or azithromycin

  • may consider:*
  • *moxifloxacin**
  • *amikacin - streptomycin**
  • *linezolid - clofazimine - trimethoprim**
20
Q

Impact of NEW TB DRUGS

3 Things

A

Treatment Duration
↑Compliance –> ↓drug resistance
↓labor in DOTS
↓cost of treatment

  • *Successful Treatment of MDR/XDR-TB**
  • *↓**transmission of MDR-TB
  • *Cure LATENT TB Infection**
  • *↓**disease reservoir
21
Q

Is this drug a Bacterial Activated PRODRUG?
What activates it?

ETHAMBUTOL

A

NOPE

inhibits arabinosyl transferase –> affects cell wall

22
Q

TB TREATMENT
for
Continuation Phase

A

4 MONTHS DAILY
kills the small% of PERSISTANT bacteria, can come back

ISONIAZID = INH

RIFAMPIN

23
Q

How does M. tb become drug-resistant
(and become progressively more so…)?

A
  • *SPONTANEOUS MUTATIONS**
  • since only confound to lungs, doesnt have a TRANSFER of RESISTANCE*

Target of Drug / Amount of Target

TB Enzymes that activate drug

Efflux Pump Activity

Cell Wall Permeability

Mutation Rates –> DNA REPAIR

24
Q

​Treatment & Duration for:

  • *EXTRAPULMONARY TB**
  • *&**
  • *TB Meningitis**
A

Std Regimen + Continuation Phase = 4 - 7 months

TB Meningitis:
Std Regimen + Continuation Phase = >10months

Dexamethasone** or **Prednisolone
tapered over 6-8 weeks –> ↓mortality

25
**Which TB Drug based on Target?** binds to: **beta-subunit** **_rpoB_** of **RNA polymerase** changes conformation -\> *prevents binding of nucleotides & inhibits initiation of transcription*
**_RIFAMYCINS_** **HEPATITIS + RED URINE** ***_INDUCTION OF CYP450 ENZYMES_*** --\> ↓**Half-Life of:** **steroids / anticoagulants / macrolides / imidazoles Protease inhibitors / NNRTIs** **Rifampin** * *Rifabutin** * less p450 activation --\> recommended for HIV/TB co-infection* * *Rifapentine** * LONG HALF LIFE --\> can be dosed WEEKLY in continuation phase*
26
**Which TB Drug based on Target?** INHIBIT: **_Mycolic Acid Synthesis_** - C60-90 alpha alkyl & target **_inhA_** = **long chain NAD-dependent _enoyl-ACP reductase_** *INH covalently attaches to nicotinamide ring of NADH@ side of hydride exhange*
* *_ISONIAZID_** = **INH** * *ETHIONAMIDE = ETH** **_*Hepatotoxicity***_ & _***PERIPHERAL NEURITIS*_** --\> **give B6** Both are: **_Bacterial-Activated Prodrugs_** **Isoniazid** is activated by **_Catalase Peroxidase_ = _katG_** **Ethionamide** is activated by **_Monooxygenase_ = _etA_**
27
**Is this drug a Bacterial Activated PRODRUG? What activates it?** **_RIFAMPIN_**
***_NOPE_*** Just binds to **rpoB** of **RNA poymerase**
28
* *Rifabutin Uses** * in comparison to RIFAMPIN*
* **_LESS ACTIVATION OF P450_*** * rifampin --\> strong p450 INDUCER* Rifamycin of choice for: **_HIV/TB Co-infection_** when using **protease inhibitors** Active vs some: **_Rifampin-resistant strains of M. TB_** use for: **_M.AVIUM_** - **intracellulare infection**
29
**_Third Line TB Agents_** approved for other disease but have no formal trials to assess efficacy in MDR/XDR TB
* *"I-C-C-T**" * order of decreasing evidence* ## Footnote **_IMIPENEM_** **_Clofazimine_** **_Clarithromycin_** ***_Thioridazine_***
30
**Rifamycin Resistance** HEPATITIS + RED URINE P450 INDUCER
**Single AA substitutions in hotspot in: _rpoB_** RNA polymerase subunit
31
**Treatment & Duration for:** **Latent TB Infection = LTBI**
**_INH ALONE_** - **9 months** or **RMP alone** - **4 months** or **INH + RifaPENTINE - 3 months** rifapentine = WEEKLY dosage
32
**Which TB Drug based on Target?** only active in vitro at **low pH \<6** Requires: **_Pyrazinamide**_ = _**pncA_** to generate the active agent = **pyrazinoic acid** **Sterilizing Activity** treatment 9mo --\> 6mo
**_PYRAZINAMIDE_** **Significant _HEPATOTOXICITY_** ↑**ALT ↑AST** *MOA IS UNCERTAIN* TB-SPECIFIC DRUG: **TB has *_deficient efflux_*** **compared to some naturally resistant mycobacteria**
33
Strategies to Prevent Development of Drug Resistance in TB treatment **_DOTS_** Directly Observed Therapy Short-course
**_Fixed Dose Combinations:_ INH + RIF + PZA (+/- *EMB)*** *1 drug regimen --\> resistance* **multiplicative resistance patterns**, **2 drugs = less resistance chance** **_Drug Susceptibility Testing_** ***_NEVER ADD 1 DRUG TO A FAILING REGIMEN_*** fact that they're failing --\> ALREADY RESISTANT